Nabil Sabbak, MD
Interventional Cardiology · Marietta, GANPI 1225492119
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Edwards Lifesciences at 40.8% of the total. 2025 is the largest year on record at $8,655, more than ten times the $793 reported in 2022.
Across 151 payments — averaging $92.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$6K
- Boston Scientific$4K
- Abbott$3K
- Medtronic$706
- Cardiovascular Systems Inc.$289
- Shockwave Medical, Inc$241
- plus $197 from 6 others
Across 54 payments — averaging $208.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$11K
What the payments were for
- Consulting fees$2,50018%
- Travel & lodging$5,05136%
- Food & beverage$6,16144%
- Education$2142%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 47 | $5,687 |
| Boston Scientific | 30 | $4,239 |
| Abbott | 43 | $2,569 |
| Medtronic | 13 | $706 |
| Cardiovascular Systems Inc. | 4 | $289 |
| Shockwave Medical, Inc | 4 | $241 |
| Cardiva Medical, Inc. | 3 | $64 |
| W. L. Gore & Associates, Inc. | 2 | $48 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $25 |
| Amgen | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Biotronik Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vitalyst$3,471
- EVOQUE$1,572
- MitraClip$876
- SAPIEN 3 Ultra RESILIA$683
- AMPLATZER$258
- Diamondback Coronary$222
- RESOLUTE ONYX$214
- GENERAL - THERAPIES$187
- OPTIS$171
- PORTICO$164
- SYMPLICITY G3$163
- DRAGONFLY OPSTAR$162
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$156
- PASCAL$145
- XIENCE SKYPOINT$133
- NAVITOR$115
- PRESSUREWIRE$107
How this compares
$13,927 in reported general payments places this provider in the 65th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 24 | $179 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Marietta
- Salvatore ManninoMarietta$275K
- Paul GuichardMarietta$260K
- Ahmed Al BadriMarietta$110K
- Arthur ReitmanMarietta$106K
- Amar PatelMarietta$73K
- Ateet PatelMarietta$24K
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Megan CoylewrightCalhoun$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.